EFFECTOR THERAPEUTICS INC (EFTR) Stock Cash Flow
NASDAQ:EFTR - Nasdaq - US28202V2079 - Common Stock - Currency: USD
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -34.63M | -35.81M | -22.66M | 15.80M | 14.21M | |||
| Depreciation Amortization | 111.00K | 111.00K | 53.00K | 24.00K | 160.00K | |||
| Change In Working Capital | 954.00K | 1.69M | 2.68M | -238.00K | -824.00K | |||
| Interest Paid | 2.60M | 2.53M | 1.82M | 1.34M | 975.00K | |||
| Other non cash items | 4.38M | 4.46M | -5.96M | -40.47M | 288.00K | |||
| OPERATING CASH FLOW | -29.19M | -29.55M | -25.90M | -24.89M | 13.84M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -84.00K | -97.00K | -192.00K | -42.00K | -154.00K | |||
| Other Investing Activity | -780.00K | 14.58M | -17.67M | 607.00K | 0.00 | |||
| INVESTING CASH FLOW | -864.00K | 14.48M | -17.86M | 565.00K | -154.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | 5.89M | -2.00M | |||
| Stock Issued/Repurchased | 35.81M | 21.23M | 2.80M | 56.00K | 108.00K | |||
| Other Financing Activity | N/A | 0.00 | -37.00K | 52.86M | 0.00 | |||
| FINANCING CASH FLOW | 35.25M | 21.23M | 2.77M | 58.81M | -1.89M | |||
| CHANGE IN CASH | 5.20M | 6.17M | -40.99M | 34.49M | 11.79M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.19M | -29.55M | -25.90M | -24.89M | 13.84M | |||
| Capital Expenditure | -84.00K | -97.00K | -192.00K | -42.00K | -154.00K | |||
| FREE CASH FLOW | -29.28M | -29.65M | -26.09M | -24.93M | 13.68M | |||
All data in USD